High Cut-off Hemodialysis Combined with Bortezomib-Based Therapy in Multiple Myeloma Patients with Severe Renal Impairment

被引：0
|
作者：
Baertsch, Marc-A. [1 ]
Raab, Marc S. [2 ]
Beimler, Joerg [3 ]
Meissner, Julia [3 ]
Schmier, Johann [3 ]
Goldschmidt, Hartmut [1 ]
Hillengass, Jens [1 ]
机构：
[1] Univ Hosp Heidelberg, Heidelberg, Baden Wurttembe, Germany
[2] Univ Clin Heidelberg, Dept Internal Med 5, Heidelberg, Germany
[3] Heidelberg Univ, Heidelberg, Germany
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2017年 / 17卷 / 01期
关键词：
D O I：
10.1016/j.clml.2017.03.218
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PS-216
引用
收藏
页码：E120 / E120
页数：1
相关论文
共 50 条
  • [31] Pharmacokinetics of lenalidomide during high cut-off dialysis in a patient with multiple myeloma and renal failure
    Dao, Kim
    Lu, Yimin
    Peer, Cody J.
    Figg, William D.
    Stadelmann, Raphael
    Burnier, Michel
    Buclin, Thierry
    Kissling, Sebastien
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (01) : 215 - 218
  • [32] Bortezomib and Dexamethasone Therapy for Newly Diagnosed Patients With Multiple Myeloma Complicated by Renal Impairment
    Li, Jian
    Zhou, Dao-Bin
    Jiao, Li
    Duan, Ming Hui
    Zhang, Wei
    Zhao, Yong Qiang
    Shen, Ti
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2009, 9 (05): : 394 - 398
  • [33] Lymphocytopenia Is Associated with an Increased Risk of Severe Infections in Patients with Multiple Myeloma Treated with Bortezomib-Based Regimens
    Jung, Sung-Hoon
    Ahn, Jae-Sook
    Kang, Seung-Ji
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. BLOOD, 2012, 120 (21)
  • [34] Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens
    Sung-Hoon Jung
    Soo-Young Bae
    Jae-Sook Ahn
    Seung-Ji Kang
    Deok-Hwan Yang
    Yeo-Kyeoung Kim
    Hyeoung-Joon Kim
    Je-Jung Lee
    [J]. International Journal of Hematology, 2013, 97 : 382 - 387
  • [35] Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
    Shijia Zhang
    Amit A. Kulkarni
    Beibei Xu
    Haitao Chu
    Taxiarchis Kourelis
    Ronald S. Go
    Michael L. Wang
    Veronika Bachanova
    Yucai Wang
    [J]. Blood Cancer Journal, 10
  • [36] Lymphocytopenia is associated with an increased risk of severe infections in patients with multiple myeloma treated with bortezomib-based regimens
    Jung, Sung-Hoon
    Bae, Soo-Young
    Ahn, Jae-Sook
    Kang, Seung-Ji
    Yang, Deok-Hwan
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (03) : 382 - 387
  • [37] Bortezomib-based consolidation or maintenance therapy for multiple myeloma: a meta-analysis
    Zhang, Shijia
    Kulkarni, Amit A.
    Xu, Beibei
    Chu, Haitao
    Kourelis, Taxiarchis
    Go, Ronald S.
    Wang, Michael L.
    Bachanova, Veronika
    Wang, Yucai
    [J]. BLOOD CANCER JOURNAL, 2020, 10 (03)
  • [38] REVERSIBILITY OF RENAL FAILURE IN MULTIPLE MYELOMA PATIENTS TREATED WITH BORTEZOMIB-BASED REGIMENS: A SINGLE CENTRE EXPERIENCE
    Stefanikova, Z.
    Roziakova, L.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 593 - 593
  • [39] BORTEZOMIB-BASED REGIMENS AS INDUCTION AND MAINTENANCE TREATMENT IN MULTIPLE MYELOMA (MM) PATIENTS NOT ELIGIBLE FOR AGGRESSIVE THERAPY
    Mazzone, C.
    Gentile, M.
    Vigna, E.
    Lucia, E.
    Lorio, C.
    Morelli, R.
    Bisconte, M. G.
    Gentile, C.
    Morabito, F.
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 544 - 544
  • [40] Comment on "Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma"
    Cavoli, Gioacchino Li
    Schillaci, Onofrio
    Zagarrigo, Carmela
    Tralongo, Angelo
    Servillo, Francesca
    Passanante, Silvia
    Rotolo, Ugo
    [J]. NEFROLOGIA, 2012, 32 (03): : 396 - 396
12345